These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9064773)

  • 21. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
    Sivenius J; Riekkinen PJ; Laakso M
    BMJ; 1995 Jan; 310(6971):25-6. PubMed ID: 7827549
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
    Findlay JM; Lougheed WM; Gentili F; Walker PM; Glynn MF; Houle S
    J Neurosurg; 1985 Nov; 63(5):693-8. PubMed ID: 3903068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet therapy in the prevention of stroke.
    Easton JD
    Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary prevention of strokes: role of platelet antiaggregant drugs in diabetic and non-diabetic patients.
    Baudoin C; Bousser MG; Haguenau M; Lefauconnier JM; Eschwege E
    Diabet Med; 1985 Mar; 2(2):145. PubMed ID: 2952402
    [No Abstract]   [Full Text] [Related]  

  • 27. [Large trials in the secondary prevention of stroke].
    Gensini GF; Simone I; Pantoni L; Inzitari D
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():102S-109S. PubMed ID: 9004808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European stroke prevention study.
    Lowenthal A
    Acta Neurol Belg; 1988; 88(1):14-8. PubMed ID: 3389069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
    Harbison JW
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Forbes CD
    Int J Clin Pract; 1997 Jun; 51(4):205-8. PubMed ID: 9287258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
    Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
    Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
    Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
    Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipyridamole with aspirin for secondary stroke prevention.
    Norrving B
    Lancet; 2006 May; 367(9523):1638-9. PubMed ID: 16714170
    [No Abstract]   [Full Text] [Related]  

  • 35. CAPRIE trial.
    Barer D
    Lancet; 1997 Feb; 349(9048):355-6. PubMed ID: 9024397
    [No Abstract]   [Full Text] [Related]  

  • 36. Does dipyridamole have antithrombotic potential?
    Loeliger EA
    Thromb Haemost; 1985 Jun; 53(3):437. PubMed ID: 4049315
    [No Abstract]   [Full Text] [Related]  

  • 37. [An acetylsalicylic acid-dypiridamole combination (Asasantine) in the prevention of the recurrence of cerebrovascular accidents (a cost-effectiveness analysis)].
    Kurz X; Annemans L; Dresse A
    Rev Med Liege; 1998 May; 53(5):265-9. PubMed ID: 9689880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors].
    Rosa A; Canaple S
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1563-8. PubMed ID: 9092419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
    Apollonio A; Castignani P; Magrini L; Angeletti R
    J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncompliance in antiplatelet trials: the AGATE trial perspective.
    Serebruany VL; Hanley DF; Atar D; Ferguson JJ
    Stroke; 2004 Jun; 35(6):e143. PubMed ID: 15087566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.